Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Upadacitinib may effectively treat alopecia areata without side effects.

Secukinumab can cause hair loss, which may improve after stopping the medication.

PCOS requires personalized treatment to improve life quality and reduce health risks.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

ILC1 cells contribute to hair loss in alopecia areata.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

N-WASP is essential for healthy skin and preventing inflammation.